Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)



Status:Active, not recruiting
Conditions:Cervical Cancer, Cancer, Women's Studies
Therapuetic Areas:Oncology, Reproductive
Healthy:No
Age Range:18 - Any
Updated:10/24/2018
Start Date:June 2012
End Date:June 2020

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The purpose of this study is to determine the maximum tolerated dose of integrated boost
radiation therapy when given with concurrent chemotherapy (cisplatin).


Inclusion Criteria:

- Biopsy confirmed malignancy of the gynecologic tract

- Involved pelvic or para-aortic lymph nodes

- Treatment plan to include delivery of concurrent chemoradiotherapy.

- Good performance status

- Negative pregnancy test in women of child-bearing potential

- Signed study-specific informed consent

- Lab results within study specific limits

Exclusion Criteria:

- Prior radiation to the abdomen or pelvis

- A history of Scleroderma or Inflammatory bowel disease

- Contraindication to chemotherapy or radiation
We found this trial at
1
site
Radiation Oncology, DUMC
Durham, North Carolina 27710
Principal Investigator: Junzo Chino, MD
Phone: 919-668-7336
?
mi
from
Durham, NC
Click here to add this to my saved trials